Smallpox-Related, Monkeypox — Worldwide/Unknown
Bavarian Nordic announced that the FDA has approved Jynneos, a live, nonreplicating vaccine for the prevention of smallpox and monkeypox disease in adults aged 18 years or older who are at a high risk for smallpox or monkeypox infection. The new vaccine from Bavarian Nordic marks the only FDA-approved vaccine for the prevention of monkeypox.
“The licensure of this vaccine not only enhances domestic biodefense and global health security but also demonstrates what can be accomplished for the
…
